Also, SBF2-AS1 can be assigned into exosomes to relocate from chemotherapy-resistant glioblastoma (GBM) cells to chemotherapy-sensitive GBM cells, thereby transferring the capacity of TMZ resistance to recipient cells. The gene discussed is SBF2; the disease is glioblastoma.